Full Text
PDF
Abstract
INTRODUCTION: The development of new pangenotypic direct-acting antivirals (pDAA) against hepatitis C virus (HCV) is revolutionizing the treatment of chronic hepatitis C (CHC). The availability of pDAA provides the opportunity to maximize Sustained Virologic Response and minimize side effects and drug-drug interactions. Given the large number of potential concomitant medications and limited pharmacokinetic data, DDIs have become a challenge in the era of DAA, particularly for patients with multiple comorbidities who use concomitant medications. OBJECTIVE: To determine the comorbidity and potential drug-drug interactions (DDIs) among DAAs associated with HCV patients in the usual clinical practice.
METHODS: This is a retrospective observational study, designed from the medical records review (computerized database). The study population was obtained from health records of healthcare provider organizations from various centers in Spain (BIG-PAC dissociated database). Patients were ≥18 years diagnosed with HCV, who required medical attention during 2018. Two groups were differentiated according to age ranges (RESULTS: Summary of results obtained 3,430 patients were recruited, the average age was 56.9 years and 60.3% were males. The distribution by age ranges was: CONCLUSION: The subjects with HCV are associated with a high comorbidity and consumption of concomitant medication, especially in older patients (≥50 yrs), a circumstance that results in greater exposure to potential DDI. The use of SOF and LDV/SOF can produce a lower proportion of contraindications (DDIs).
Most read articles by the same author(s)
- Nilay Danış, Hüseyin Döngelli, Tarkan Ünek, Aylin Bacakoğlu, İlker Turan, Abdullah Zeki Karasu, Fulya Günşar, Elvan Işık, Muhsin Murat Harputluoglu, Kutay Sağlam, Sezai Yılmaz, Bilger Çavuş, Sabahattin Kaymakoglu, Haydar Adanır, Dinç Dinçer, Derya Arı, Meral Akdogan Kayhan, Dilara Turan Gokce, Gökhan Kabacam, Sedat Karademir, Murat Kıyıcı, Selcan Cesur, Hale Gokcan, Zeynep Melekoglu Ellik, Ramazan İdilman, Murat Dayangaç, Yasemin Balaban, Ahmet Bulent Dogrul, Hilmi Anıl Dinçer, Gupse Adalı, Feyza Dilber, Murat Taner Gulsen, Orhan Sezgin, Zekiye Nur Harput, Murat Akyıldız, Kenan Moral, Tufan Egeli, Cihan Ağalar, Mücahit Özbilgin, Mesut Akarsu, De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes , Turkish Journal of Gastroenterology: Vol. 37 No. 4 (2026): Turkish Journal of Gastroenterology
- Kadir Demir, Aslı Çifcibaşı Örmeci, Bilger Çavuş, Zülal İstemihan, Sezen Genç, Alp Atasoy, Filiz Akyüz, Fatih Beşışık, Sabahattin Kaymakoğlu, Maternal and Fetal Outcomes of Pregnancies in Wilson’s Disease: A Single-Centre Real-Life Experience , Turkish Journal of Gastroenterology: Vol. 37 No. 3 (2026): Turkish Journal of Gastroenterology
- Filiz Akyüz, Altay Çelebi, İbrahim Doğan, Yusuf Erzin, Taylan Kav, Müjde Soytürk, Dilek Oğuz, Birol Özer, Sabahattin Kaymakoğlu, Functional Bowel Disorder Management in Routine Practice with Tips for Hot Topics: Expert Opinion Review , Turkish Journal of Gastroenterology: Vol. 35 No. 6 (2024): Turkish Journal of Gastroenterology
- Sabahattin Kaymakoğlu, İftihar Köksal, Fehmi Tabak, Ulus S. Akarca, Ayhan Akbulut, Filiz Akyüz, Hürrem Bodur, Atahan Çağatay, Dinç Dinçer, Şaban Esen, Rahmet Güner, Selim Gürel, Şükran Köse, Ömer Şentürk, Halis Şimşek, Tansu Yamazhan, Yusuf Yılmaz, Ramazan Idilman, and Viral Hepatisis Guideline Study Group, Recommendation for treatment of hepatitis C virus infection , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Fehmi Tabak, Cihan Yurdaydın, Sabahattin Kaymakoğlu, Mesut Akarsu, Esra G. Akıncı, Hikmet Akkız, Canan Alkım, Ayhan H. Çekin, Nefise Ö. Çuvalcı, Kadir Demir, Bülent Değertekin, İlyas Dökmetaş, Galip Ersöz, Kenan Hizel, Fatma Ö. Kandemir, Yusuf Önlen, Abdullah Sonsuz, Ebubekir Şenateş, Selma Tosun, Nurdan Tözün, Ramazan Idilman, and Viral Hepatisis Guideline Study Group, Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Ramazan Idilman, Nurcan Baykam, Sabahattin Kaymakoğlu, Fehmi Tabak, Halil İ. Bahçecioğlu, Ahmet Bektaş, Cemal Bulut, Fulya Günşar, Dilara İnan, Hayat K. Karaosmanoğlu, Zeki Karasu, Ferit Kuşçu, Birgül Mete, Ömer Özbakır, Osman C. Özdoğan, Mehmet Parlak, Fatma Sırmatel, Ömer Topalak, Belkis Ünsal, and Viral Hepatisis Guideline Study Group, Turkey 2017 Clinical Practice Guidelines on recommendations for screning diagnosing and managing hepatitis C virus , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Cihan Yurdaydın, Fehmi Tabak, Sabahattin Kaymakoğlu, Mesut Akarsu, Esra G. Akıncı, Hikmet Akkız, Canan Alkım, Ayhan H. Çekin, Nefise Ö. Çuvalcı, Kadir Demir, Bülent Değertekin, İlyas Dökmetaş, Galip Ersöz, Kenan Hizel, Fatma Ö. Kandemir, Yusuf Önlen, Abdullah Sonsuz, Ebubekir Şenateş, Selma Tosun, Nurdan Tözün, Ramazan Idilman, and Viral Hepatisis Guideline Study Group, Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Gökhan Kabaçam, Murat Dayangaç, Enver Üçbilek, Cemal Nuri Erçin, Fulya Günsar, Murat Akyıldız, Mesut Akarsu, Mehmet Demir, Sabahattin Kaymakoğlu, Zeki Karasu, Ramazan İdilman, The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists , Turkish Journal of Gastroenterology: Vol. 31 No. 5 (2020): Turkish Journal of Gastroenterology
- Erol AVŞAR, Arzu TİFTİKÇİ, Şule POTUROĞLU, Yusuf Erzin, Ozan KOCAKAYA, Dinç DİNÇER, Bulut YILDIRIM, Sefa GÜLİTER, Cansel TÜRKAY, Uğur Yılmaz, Mehmet Derya ONUK, Cengiz BÖLÜKBAŞ, Ender ELLİDOKUZ, Ahmet BEKTAŞ, Güralp TAŞAN, Necip AYTUĞ, Yüksel ATEŞ, Sabahattin KAYMAKOĞLU, A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazolebased triple therapy for the eradication of Helicobacter pylori in dyspeptic patients , Turkish Journal of Gastroenterology: Vol. 24 No. 4 (2013): Turkish Journal of Gastroenterology
- Fatih Kemik, Gozde Ceylan, Abdurrahman F. Aydin, Bilger Çavuş, Asli Ormeci, Ziya Imanov, Ibrahim V. Senkal, Kenan Nuriyev, Zulal Istemihan, Filiz Akyuz, Selman F. Besisik, Sabahattin Kaymakoglu, Kadir Demir, The Role of Pancreatic Enzyme Insufficiency in the Etiology of Functional Dyspepsia Resistant to Standard Treatment , Turkish Journal of Gastroenterology: Vol. 36 No. 7 (2025): Turkish Journal of Gastroenterology
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 30 · Issue Supplement 1
Pages
43-45
History
Published Online
July 25, 2019
Copyright
Copyright (c) 2019 Antoni Sicras Mainar, Sabahattin Kaymakoglu
Affiliations
Antoni Sicras Mainar
Scientific Direction Real Life Data Badalona Barcelona Spain
Sabahattin Kaymakoglu
Department of Gastroenterology Istanbul University Istanbul Medical Faculty Istanbul Turkey
Cite this Article
Mainar, A. S., & Kaymakoglu, S. (2019). Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medication with patients with chronic hepatitis C virus infection. Turkish Journal of Gastroenterology, 30(Supplement 1), 43–45. https://doi.org/10.5152/tjg.2019.28
Outlines